Business Context and Reporting Period
Company: DaVita HealthCare Partners Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 24, 2014
Event: Entry into a new material definitive credit agreement and termination of a prior credit agreement.
Key Financial Metrics and Capital Structure
This filing details a refinancing transaction rather than operational financial results. Key capital structure metrics include:
- New Credit Facility Total: $5.5 billion senior secured credit agreement.
- Revolving Credit Facility: $1.0 billion, maturing June 2019.
- Term Loan A: $1.0 billion, maturing June 2019.
- Term Loan B: $3.5 billion, maturing June 2021.
- Interest Margins (LIBOR): 1.75% for Revolver and Term Loan A; 2.75% for Term Loan B.
- Collateral: Substantially all tangible and intangible assets of the Company and guarantors.
Material Changes Versus Prior Period
The Company terminated its Prior Credit Agreement (dated October 20, 2010) and replaced it with the new facility. Proceeds from the new agreement were used to repay all outstanding amounts under the prior agreement.
Prior Credit Agreement Composition (as of March 31, 2014):
- Revolving Line: $350 million (none outstanding).
- Term Loan A: $762.5 million.
- Term Loan A-3: $1,265.625 million.
- Term Loan B: $1,693.125 million.
- Term Loan B-2: $1,629.375 million.
Changes in Terms: The new agreement consolidates the debt structure and adjusts interest margins. The Term Loan B facility includes a LIBOR floor of 0.75%, whereas the prior Term Loan B had a floor of 1.50% and Term Loan B-2 had a floor of 1.00%.
Guidance, Outlook, and Other Events
Covenants: The new agreement includes a maximum leverage ratio financial covenant. Operating covenants restrict additional indebtedness, asset dispositions, investments, and dividend payments.
Tender Offer and Redemption: The Company is conducting a tender offer for its 6-3/8% Senior Notes due 2018. As of June 23, 2014, approximately $483 million of these notes were tendered. The Company notified holders that all remaining notes not tendered will be redeemed on July 24, 2014, at a price of 104.781% of the principal amount plus accrued interest.
Management Commentary: The filing does not provide specific management commentary on future operational outlook or revenue guidance, focusing solely on the capital restructuring.
Investor Verification Checklist
- Verify the final amount of 2018 Senior Notes tendered and the total cash outflow required for the redemption of non-tendered notes on July 24, 2014.
- Confirm the Company's current leverage ratio to ensure compliance with the new maximum leverage covenant.
- Review the impact of the new interest rate margins and LIBOR floors on future interest expense compared to the prior agreement.
- Assess the implications of the new operating covenants on the Company's ability to pay dividends or make strategic investments.